InfuSystem Holdings (INFU) Property, Plant & Equipment (Net) Growth (3y) (2013 - 2026)
InfuSystem Holdings (INFU) Property, Plant & Equipment (Net) Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 10.07% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 8.57% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 9.71% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 17.92% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 3.47% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 13.19% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 9.97% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 9.80% |
| 10 | InfuSystem Holdings | 189.78 Mn | 187.68 Mn | 19.68 Mn | -9.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.85% |
| Dec 31, 2025 | -8.50% |
| Sep 30, 2025 | -4.65% |
| Jun 30, 2025 | -4.04% |
| Mar 31, 2025 | -3.58% |
| Dec 31, 2024 | -3.77% |
| Sep 30, 2024 | -4.05% |
| Jun 30, 2024 | -1.13% |
| Mar 31, 2024 | -0.75% |
| Dec 31, 2023 | 0.19% |
| Sep 30, 2023 | -0.41% |
| Jun 30, 2023 | -0.92% |
| Mar 31, 2023 | 0.07% |
| Dec 31, 2022 | 2.79% |
| Sep 30, 2022 | 13.96% |
| Jun 30, 2022 | 40.95% |
| Mar 31, 2022 | 47.33% |
| Dec 31, 2021 | 46.28% |
| Sep 30, 2021 | 43.62% |
| Jun 30, 2021 | 41.02% |